Jounce Names Ex-Ariad's Top Dealmaker as Its New CBO
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"Jounce Names Ex-Ariad's Top Dealmaker as Its New CBO" ALT"Jounce Names Ex-Ariad's Top Dealmaker as Its New CBO"August 16, 2017By Alex Keown, BioSpace.com Breaking News StaffCAMBRIDGE, Mass. ...…
Coherus Files PTAB Petition Against Amgen’s Enbrel
Coherus BioSciences filed a petition with the PTO for an inter partes review of a patent on production methods for Amgen’s Enbrel (etanercept), saying the claims are obvious and unpatentable.…
Two Compounding Pharmacies Lose Exemptions, Draw FDA Flags
Two compounders forfeited their exemptions as compounding pharmacies from certain FDA rules because they made products that were not formulated in response to prescriptions for individual patients, the agency said.…
FDA Asks Drugmakers to Report PDUFA-Eligible Products, Orange Book Changes
In anticipation of the passage of PDUFA VI, the FDA called on drug companies to notify agency officials of any PDUFA eligible products and Orange Book changes involving their products…
EMA Updates EudraVigilance Q&As With Over 100 Questions From Sponsors
More than 120 questions and answers were added to the European Medicines Agency’s FAQs on the launch of the new EudraVigilance reporting system, set to go live Nov. 22. Source:…
STAAR Surgical And Announce Strategic Cooperation Agreement
Life Sciences Jobs ... Source: BioSpace
Struggling Teva Loses Top R&D Exec To Eli Lilly, Novartis AG-Backed Cavion
Life Sciences Jobs ... Source: BioSpace
GeneNews Announces Q2-2017 Financial Results & Provides Progress Update
Life Sciences Jobs ... Source: BioSpace
- Go to the previous page
- 1
- …
- 349
- 350
- 351
- 352
- 353
- 354
- 355
- …
- 610
- Go to the next page